Reply to Thomas Gevaert, Markus Eckstein, Rodolfo Montironi, and Antonio Lopez-Beltran's Letter to the Editor re: Maud Rijnders, Astrid AM van der Veldt, Tahlita CM Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538-40

被引:0
|
作者
Rijnders, Maud [1 ]
van der Veldt, Astrid A. M. [1 ,2 ]
de Wit, Ronald [1 ]
van Leenders, Geert J. L. H. [3 ]
机构
[1] Erasmus MC Canc Inst, Univ Med Ctr, Dept Med Oncol, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands
[2] Erasmus MC, Univ Med Ctr, Dept Radiol & Nucl Med, Rotterdam, Netherlands
[3] Erasmus MC Canc Inst, Univ Med Ctr, Dept Pathol, Rotterdam, Netherlands
关键词
PEMBROLIZUMAB; ATEZOLIZUMAB; MULTICENTER; THERAPY; ASSAYS;
D O I
10.1016/j.eururo.2019.01.039
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E160 / E161
页数:2
相关论文
共 4 条